Phosphagenics (ASX: POH) is a Melbourne-based biotechnology company. Its core technology is built around the science and application of TPM™ delivery systems. This system enables transdermal delivery of proven pharmaceutical actives and enhances dermal delivery of pharmaceutical, cosmeceutical and nutraceutical actives.
Phosphagenics’ oxycodone patch found to provide pain relief to racehorses
Wednesday, May 21, 2014 by Proactive Investors
The proof of concept study was conducted on six thoroughbreds with shin bone soreness arising from injuries in either one or two limbs.
A TPM®/Oxycodone patch was applied daily to each injured limb for ten days.
The study results showed there were no signs of lameness and five horses treated were pain-free within 24 hours following the first patch application.
While the sixth horse was pain-free by the second patch application within 48 hours.
Significantly, pain relief from use of the patch allowed the animals to recover without the enduring stress normally associated with such injuries.
Gastric ulceration is one of the biggest health issues for thoroughbred racehorses according to a recent Racing Victoria report.
The topical nature of the patch’s delivery system means gastric ulceration associated with some systemic drug treatments, such as the NSAID Phenylbutazone, could be eliminated.
The racehorse study has demonstrated that a significant new market is opening up for Phosphagenics’ TPM®/Oxycodone patch also in the companion animal market.
Which at 40% of the global $23 billion annual animal health market – is a prize.
The results of the racehorse study are also extremely positive for the use of the patch in the $12 billion annual market for neuropathic pain for humans.
Phosphagenics’ Phase 2 trial of TPM®/Oxycodone for human use is due to commence next quarter.
The racehorse study has positive ramifications for the business development of the TPM®/Oxycodone patch.
We are encouraged by these results in the proof of concept study, and consider it value accretive.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.
Sign up to Andrew McCrea’s Research Reports and Receive Latest Research & Flash Trades
Receive Proactive Investors Newsletter, Event Invites, Special Stock Notifications